gri-0621
Generic: tazarotene
gri-0621: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| GRI Bio, Inc. (GRI) | Phase 2 |
Get deeper analysis on gri-0621
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis